Development and Characterization of a Human and Mouse Intestinal Epithelial Cell Monolayer Platform

• Published in: Stem cell reports 2017-12, Vol.9 (6), p.1976-1990
• Main Authors: Kozuka, Kenji, He, Ying, Koo-McCoy, Samantha, Kumaraswamy, Padmapriya, Nie, Baoming, Shaw, Karen, Chan, Priscilla, Leadbetter, Michael, He, Limin, Lewis, Jason G., Zhong, Ziyang, Charmot, Dominique, Balaa, Marwan, King, Andrew J., Caldwell, Jeremy S., Siegel, Matthew
• Format: Article
• Language: English
• Subjects: colon; colonoid; enteroid; intestinal epithelium; monolayer; organoids; phenotype screening assays; small intestine
• ISSN: 2213-6711; 2213-6711
• DOI: 10.1016/j.stemcr.2017.10.013

We describe the development and characterization of a mouse and human epithelial cell monolayer platform of the small and large intestines, with a broad range of potential applications including the discovery and development of minimally systemic drug candidates. Culture conditions for each intestinal segment were optimized by correlating monolayer global gene expression with the corresponding tissue segment. The monolayers polarized, formed tight junctions, and contained a diversity of intestinal epithelial cell lineages. Ion transport phenotypes of monolayers from the proximal and distal colon and small intestine matched the known and unique physiology of these intestinal segments. The cultures secreted serotonin, GLP-1, and FGF19 and upregulated the epithelial sodium channel in response to known biologically active agents, suggesting intact secretory and absorptive functions. A screen of over 2,000 pharmacologically active compounds for inhibition of potassium ion transport in the mouse distal colon cultures led to the identification of a tool compound. •Epithelial cell monolayer growth conditions developed for all intestinal segments•Monolayer gene expression is consistent with tissue from each intestinal segment•Ion transport, secretory, and absorptive functions match intestinal physiology•Compound screen identified inhibitor of mouse distal colon potassium transport Siegel and colleagues describe their development of a human and mouse intestinal epithelial cell monolayer platform that maintains the cellular, molecular, and functional characteristics of tissue for each intestinal segment. They demonstrate the platform's application to drug discovery by screening a library of over 2,000 compounds to identify an inhibitor of potassium ion transport in the mouse distal colon.